INFLIXIMAB, RECOMBINANT for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

There are 23 adverse event reports in the FDA FAERS database where INFLIXIMAB, RECOMBINANT was used for Psoriasis.

Most Reported Side Effects for INFLIXIMAB, RECOMBINANT

Side Effect	Reports	%	Deaths	Hosp.
Pneumocystis jirovecii pneumonia	29	11.4%	1	22
Off label use	21	8.2%	2	6
Infusion related reaction	18	7.1%	0	5
Histoplasmosis disseminated	16	6.3%	0	12
Tuberculosis	15	5.9%	0	0
Lupus-like syndrome	13	5.1%	1	2
Pulmonary tuberculosis	12	4.7%	0	3
Drug ineffective	11	4.3%	0	2
Pneumonia	11	4.3%	1	7
Crohn's disease	9	3.5%	0	6
Disseminated tuberculosis	7	2.8%	0	2
Immune reconstitution inflammatory syndrome	7	2.8%	0	5
Infection	6	2.4%	3	1
Drug ineffective for unapproved indication	5	2.0%	1	1
Neoplasm malignant	5	2.0%	1	1